Zhao Lifu, Dai Wangde, Carreno Juan, Shi Jianru, Kleinman Michael T, Kloner Robert A
Huntington Medical Research Institutes, Pasadena, CA, 91105, USA.
Keck School of Medicine of the University of Southern California, Los Angeles, CA, 90017-2395, USA.
Heliyon. 2020 Nov 16;6(11):e05450. doi: 10.1016/j.heliyon.2020.e05450. eCollection 2020 Nov.
We investigated the acute effects of nicotine on myocardial infarct size, no reflow, hemodynamics and cardiac function in an acute myocardial ischemia and reperfusion infarction rat model.
Female Sprague-Dawley rats (n = 23/group) received an intravenous loading dose of nicotine at 2.0 μg/kg/min or saline control for 30 min before starting coronary artery occlusion, then followed by a maintenance dose 0.35 μg/kg/min of nicotine to the end of 30 min occlusion and 3 h reperfusion.
At baseline, there was no difference in systolic blood pressure (BP in mmHg) (nicotine, 69.0 ± 2.7; control, 69.3 ± 4.4; = NS) or diastolic BP (nicotine, 45.7 ± 3.2; control, 48.2 ± 4.2; = NS) between groups. Nicotine administration initially increased systolic BP (nicotine, 97.0 ± 8.6; control, 69.2 ± 3.3, 0.0001) and diastolic BP (nicotine, 65.6 ± 6.4; control, 47.4 ± 3.1, = 0.0003) at 10 min after starting injection of the loading dose; BP dropped to control levels in both groups at 30 min. During occlusion and reperfusion, the BP and heart rate were not altered by nicotine. Nicotine significantly increased myocardial infarct size as a percentage of the ischemic risk zone compared to the controls (nicotine, 54.9 ± 1.9; control, 48.6 ± 2.7, < 0.05), but nicotine did not affect the no-reflow size and heart function.
While acute nicotine only transiently elevated blood pressure, it did not affect hemodynamic parameters during coronary artery occlusion. Nicotine increased myocardial infarct size, suggesting that the increase in infarct size was not simply due to an increase in oxygen demand due to altered afterload, heart rate, or contractility, but may have been due to a more direct effect on the myocardium.
我们在急性心肌缺血再灌注梗死大鼠模型中研究了尼古丁对心肌梗死面积、无复流现象、血流动力学和心脏功能的急性影响。
雌性斯普拉格-道利大鼠(每组23只)在冠状动脉闭塞开始前30分钟接受2.0μg/kg/min的尼古丁静脉负荷剂量或生理盐水对照,然后在30分钟闭塞期结束和3小时再灌注期给予0.35μg/kg/min的尼古丁维持剂量。
在基线时,两组间收缩压(mmHg)(尼古丁组,69.0±2.7;对照组,69.3±4.4;P =无显著性差异)或舒张压(尼古丁组,45.7±3.2;对照组,48.2±4.2;P =无显著性差异)无差异。在开始注射负荷剂量后10分钟,尼古丁给药最初使收缩压升高(尼古丁组,97.0±8.6;对照组,69.2±3.3,P = 0.0001)和舒张压升高(尼古丁组,65.6±6.4;对照组,47.4±3.1,P = 0.0003);30分钟时两组血压均降至对照水平。在闭塞和再灌注期间,尼古丁未改变血压和心率。与对照组相比,尼古丁显著增加了心肌梗死面积占缺血危险区的百分比(尼古丁组,54.9±1.9;对照组,48.6±2.7,P < 0.05),但尼古丁不影响无复流面积和心脏功能。
虽然急性尼古丁仅短暂升高血压,但在冠状动脉闭塞期间不影响血流动力学参数。尼古丁增加了心肌梗死面积,表明梗死面积增加并非仅仅由于后负荷、心率或收缩性改变导致的氧需求增加,而可能是由于对心肌有更直接的影响。